logo

Risperidone for the core symptom domains of autism: results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Christopher J. McDougle, Lawrence Scahill, Michael G. Aman, James T. McCracken, Elaine Tierney, Mark Davies, L. Eugene Arnold, David J. Posey, Andrès Martin, Jaswinder K. Ghuman, Bhavik G. Shah, Shirley Z. Chuang, Naomi B. Swiezy, Nilda M. Gonzalez, Jill A. Hollway, Kathleen Koenig, James McGough, Louise Ritz, Benedetto Vitiello
Title
Risperidone for the core symptom domains of autism: results from the study by the Autism Network of the Research Units on Pediatric Psychopharmacology.
Journal
American Journal of Psychiatry
Year
2005
Volume
162
Issue
6
Page(s)
pp. 1142-1148
Full Item
Read Full Item (New Window)
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Retrospective Study, Peer-Reviewed
Comments

This is an extension study of the paper by the Research Units on Pediatric Psychopharmacology Autism Network (2002). This study tested the hypothesis that risperidone is superior to placebo for reducing repetitive behavior and that it improves measures of social relatedness and impaired communication.

Keywords
Risperidone, Restricted, Repetitive Patterns of Behaviour, Interests, or Activities, Adolescent / Secondary School Age, Antipsychotics, Atypical, Autism, Child/Children, Core/Global Functioning/Symptoms, Intervention, Medication

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Related Interventions


Related Publications


Publications | Publications Database | Search Publications